AIM1 PROMOTER HYPERMETHYLATION AS A PREDICTOR OF DECREASED RISK OF RECURRENCE FOLLOWING RADICAL PROSTATECTOMY

PURPOSE: To evaluate the prognostic significance of six epigenetic biomarkers (AIM1, CDH1, KIF1A, MT1G, PAK3 and RBM6 promoter hypermethlation) in a homogeneous group of prostate cancer patients, following radical prostatectomy. PATIENTS AND METHODS: Biomarker analyses were performed retrospectively...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Rosenbaum, Eli, Begum, Shahnaz, Brait, Mariana, Zahurak, Marianna, Maldonado, Leonel, Eisenberger, Mario A, Epstein, Jonathan I, Partin, Alan W, Sidransky, David, Hoque, Mohammad Obaidul
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3360823/
https://ncbi.nlm.nih.gov/pubmed/22127895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.22461
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak